Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Novo Nordisk A/S (NVO) vs Vanguard Real Estate Index Fund ETF (VNQ) Price & Performance

Novo Nordisk A/STrade
Vanguard Real Estate Index Fund ETFTrade

Price performance (Past 24H)

Key statistics

Novo Nordisk A/S vs Vanguard Real Estate Index Fund ETF — how do they compare? Novo Nordisk A/S trades at $49.32 (market cap $220.53B), while Vanguard Real Estate Index Fund ETF trades at $99.41. The key difference: Novo Nordisk A/S pays a 3.63% dividend while Vanguard Real Estate Index Fund ETF pays none, and Vanguard Real Estate Index Fund ETF is trading nearer its 52-week high, Novo Nordisk A/S nearer its low. Which is the better fit depends on your goals.

NVOVNQ
Market Cap
$220.53B
Sector
Health
52-Week High
$71.70$100.07
52-Week Low
$35.29$87.00
Enterprise Value
$239.49B
Dividend Yield
3.63%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Novo Nordisk A/S

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Read more on NVO

About Vanguard Real Estate Index Fund ETF

The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Real Estate 25/50 Index, an index made up of stocks of large, mid-size, and small US companies within the real estate sector. The Advisor attempts to replicate the target index by seeking to invest all of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. It is non-diversified.

Read more on VNQ